Evidence map›Paper›PMID 34479042›Full record

ArticlePreventive veterinary medicine2021

Household and animal factors associated with sheeppox and goatpox sero-prevalence and identification of high-risk areas in selected States of northern Nigeria.

Adeyinka J Adedeji, Sandra I Ijoma, Rebecca B Atai, Banenat B Dogonyaro, Jolly A Adole, Nanven A Maurice, Onyekachukwu H Osemeke, Ibrahim A Waziri, Yakubu J Atuman, Nicholas A Lyons and 3 more

Open access · hybridAbstract read
In one paragraph

Article in Preventive veterinary medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.3field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 3 countries.

Adeyinka J AdedejiNational Veterinary Research Institute, Vom, Nigeria.
Sandra I IjomaNational Veterinary Research Institute, Vom, Nigeria.
Rebecca B AtaiNational Veterinary Research Institute, Vom, Nigeria.
Banenat B DogonyaroNational Veterinary Research Institute, Vom, Nigeria.
Jolly A AdoleNational Veterinary Research Institute, Vom, Nigeria.
Nanven A MauriceNational Veterinary Research Institute, Vom, Nigeria.
Onyekachukwu H OsemekeNational Veterinary Research Institute, Vom, Nigeria.
Ibrahim A WaziriNational Veterinary Research Institute, Vom, Nigeria.
Yakubu J AtumanNational Veterinary Research Institute, Vom, Nigeria.
Nicholas A LyonsThe Pirbright Institute, Pirbright, UK; European Commission for the Control of Foot-and-Mouth Disease (EuFMD), Food and Agriculture Organization of the United Nations, Rome, Italy.
Kim B StevensThe Royal Veterinary College, Hatfield, UK.
Philippa M BeardThe Pirbright Institute, Pirbright, UK; The Roslin Institute and Royal (Dick) School of Veterinary Studies, Midlothian, UK.
Georgina LimonThe Pirbright Institute, Pirbright, UK; The Royal Veterinary College, Hatfield, UK. Electronic address: georgina.limon-vega@pirbright.ac.uk.
National Veterinary Research Institute · NGThe Pirbright Institute · GBRoyal Veterinary College · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sheeppox and goatpox (SGP) are transboundary, highly contagious diseases affecting sheep and goats with characteristic clinical signs. SGP affect populations of small ruminants in Africa, Asia and the Middle East and, as a result, threaten farmers' livelihoods. Despite their importance, studies looking at factors that increase the risk of sheeppox-virus (SPPV) and goatpox-virus (GTPV) exposure and infection are limited. A cross-sectional study was conducted in three states of Northern Nigeria (Bauchi, Kaduna and Plateau) to determine the sero-prevalence and spatial patterns of SGP, and identify risk factors for SPPV/GTPV exposure at animal and household level. Sera samples were collected from 1,800 small ruminants from 300 households. Data on putative risk factors were collected using a standardised questionnaire. Twenty-nine small ruminants were sero-positive to SGP - apparent weighted sero-prevalence 2.0 %; 95 % C.I. 1.1-.3.0 %. Sero-positive animals came from 19 (6.3 %) households. Analysis of the questionnaire showed that a fifth (20.3 %) of farmers claimed to have experienced SGP outbreaks previously in their flocks, with 33 (1.8 %) of the individual animals sampled in this study reported to have had clinical signs. At animal level, the odds of being sero-positive were higher in older animals (>24months; OR = 8.0, p = 0.008 vs ≤24 months) and small ruminants with a history of clinical SGP (OR = 16.9, p = 0.01). Bringing new small ruminants into the household and having a history of SGP in the flock were the main factors identified at household level. Households were less likely to be sero-positive if the time between bringing animals into the household and sampling was over a year (PR = 0.31, p = 0.05), while households with a history of SGP were more likely to be sero-positive regardless of the timeframe. Important spatial heterogeneity was found. The Bayes smooth rate ranged from 0.06 to 4.10 % across local government areas (LGA), with LGA in the north-east or north-west of the study area identified as hot-spots for SGP exposure. Results from this study shed new light on the understanding of SGP epidemiology and provide key inputs to design risk-based surveillance and intervention programmes in the area.

Indexed as

Goat DiseasesSheep DiseasesAnimalsBayes TheoremCapripoxvirusCross-Sectional StudiesGoatsNigeriaPoxviridae InfectionsPrevalenceSheepGoatpoxNigeriaRisk factorsSero-prevalenceSheeppoxSubsistence farmers

Identifiers

PMID34479042
PMCPMC8573585
OpenAlexW3193485111

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.